Advertisement
UK markets close in 7 hours 17 minutes

  • FTSE 100

    8,428.56
    +47.21 (+0.56%)
     

  • FTSE 250

    20,601.58
    +70.28 (+0.34%)
     

  • AIM

    785.82
    +2.12 (+0.27%)
     

  • GBP/EUR

    1.1620
    +0.0009 (+0.08%)
     

  • GBP/USD

    1.2530
    +0.0006 (+0.05%)
     

  • Bitcoin GBP

    50,225.39
    +1,328.91 (+2.72%)
     

  • CMC Crypto 200

    1,308.01
    -50.00 (-3.68%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • DOW

    39,387.76
    +331.36 (+0.85%)
     

  • CRUDE OIL

    79.82
    +0.56 (+0.71%)
     

  • GOLD FUTURES

    2,374.30
    +34.00 (+1.45%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,966.03
    +428.22 (+2.31%)
     

  • DAX

    18,797.06
    +110.46 (+0.59%)
     

  • CAC 40

    8,234.39
    +46.74 (+0.57%)
     
PROPERTY:

Homes with investment potential

These residential properties could bring in a good ROI

Biotech Short Sellers Run for Cover

Chris Lange

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, with big potential upside and big potential downside. As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.

As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.

ALSO READ: The 6 Most Shorted Nasdaq Stocks

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The December 30 short interest data have been compared with the previous report, and short interest was down in most of the selected stocks.

ADVERTISEMENT

Amgen Inc. (AMGN) saw its short interest decrease to 6.22 million shares from the previous level of 6.90 million. Shares were last seen trading at $156.62, in a 52-week trading range of $133.64 to $176.85.

Biogen Inc. (BIIB) had its short interest increase to 2.07 million shares from the previous 1.99 million. The stock was recently trading at $287.11, within a 52-week range of $223.02 to $333.65.

ALSO READ: The Worst CEOs of 2016

Celgene Corp.'s (CELG) short interest for this settlement date decreased to 7.67 million shares from the previous 7.71 million. Shares were changing hands at $117.24, in a 52-week range of $93.05 to $127.00.

Gilead Sciences Inc. (GILD) saw its short interest decrease to 13.37 million shares from 14.98 million in the previous period. Shares were trading at $73.77, in a 52-week trading range of $70.83 to $103.10.

MannKind Corp. (MNKD) saw the number of its shares short decrease to 98.60 million. The previous reading was 106.22 million. The stock was last seen at $0.63, in a 52-week range of $0.41 to $2.24. Note that MannKind is one of the most shorted Nasdaq stocks.

ALSO READ: America's Most Hated Companies

Alexion Pharmaceuticals Inc.’s (ALXN) short interest increased to 5.55 million, compared to the previous level of 5.50 million. Shares were recently trading at $136.66, in a 52-week range of $109.12 to $169.84.

Related Articles